title: Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications.
authors.affiliation: Cattedra di Oncologia Medica, Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Facoltà di Medicina, Università Federico II, Naples, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Tagliaferri
authors.forename: R
authors.initials: R
authors.lastname: Guarrasi
authors.forename: M
authors.initials: M
authors.lastname: Caraglia
authors.forename: D
authors.initials: D
authors.lastname: Morelli
authors.forename: A
authors.initials: A
authors.lastname: Fabbrocini
authors.forename: P
authors.initials: P
authors.lastname: Correale
authors.forename: A R
authors.initials: AR
authors.lastname: Bianco
mesh_terms: D000818:Animals; D016207:Cytokines / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy
chemical_list: D016207:Cytokines; D007376:Interleukin-2